School-Age Outcomes following a Randomized Controlled Trial of Magnesium Sulfate for Neuroprotection of Preterm Infants - 22/07/14
, Maya Enser, MD 3, Estelle Houivet, MSc 4, Delphine Provost, MD 3, Jacques Bénichou, MD, PhD 4, Loïc Marpeau, MD 2, 5, Stéphane Marret, MD, PhD 1, 2Abstract |
In a French randomized trial, children at school-age demonstrated no evidence of harm from fetal exposure to MgSO4 before very preterm birth. Motor dysfunction/death, qualitative behavioral disorders, cognitive difficulties, school grade repetition, and education services were decreased in the children exposed to MgSO4, although the differences were not significant.
Le texte complet de cet article est disponible en PDF.Keyword : CP, SDQ
Plan
| This follow-up study was funded by the European Regional Development Fund and the Upper-Normandy region. The authors declare no conflicts of interest. |
|
| Registered with ClinicalTrials.gov: NCT00120588. |
Vol 165 - N° 2
P. 398 - août 2014 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
